Neuropathic Pain

Health — James William Steven Parker

Neuropathic Pain is pain caused by a lesion or disease affecting the somatosensory nervous system. This definition distinguishes it from ordinary nociceptive pain, which arises from activation of pain receptors by tissue injury or inflammation without primary damage to the sensory nervous system itself. Neuropathic pain can result from injury to peripheral nerves, nerve roots, spinal cord pathways or relevant brain structures.

Common examples include painful diabetic neuropathy, post-herpetic neuralgia, radicular pain in selected cases and pain following certain neurological injuries. The pain is often described as burning, electric, shooting, stabbing or shock-like, although no particular descriptive word is sufficient for diagnosis. Neuropathic pain can coexist with other mechanisms, meaning that a person may simultaneously experience nociceptive and neuropathic pain in the same anatomical region.

The biological basis of neuropathic pain involves abnormal activity and processing within damaged or diseased sensory pathways. Injured nerves can develop spontaneous ectopic electrical activity, altered ion-channel expression and increased sensitivity to mechanical or chemical stimuli. At the spinal cord level, repeated abnormal input can alter synaptic processing and contribute to central sensitisation. In some circumstances, inhibitory control mechanisms become less effective, allowing nociceptive information to be amplified. Glial cells, inflammatory mediators and changes in neuronal connectivity can also participate. These mechanisms help explain why neuropathic pain can persist after the original injury has stabilised and why the intensity of pain does not necessarily correspond to the apparent severity of structural nerve damage.

Neuropathic pain can produce both positive and negative sensory symptoms. Positive symptoms include burning pain, electric shocks, pins and needles, tingling, abnormal sensations and pain caused by normally innocuous touch. Allodynia is pain produced by a stimulus that would not normally be painful, such as light clothing touching the skin. Hyperalgesia refers to increased pain from a stimulus that is normally painful. Negative symptoms include reduced or absent sensation, numbness and loss of temperature or vibration perception.

The coexistence of numbness and severe pain is not contradictory because damaged nerves can simultaneously lose normal signalling and generate abnormal spontaneous activity. Distribution is also informative: peripheral neuropathy often produces distal, length-dependent symptoms, while a single compressed nerve root may produce a more anatomically restricted pattern.

Diagnosis requires identifying evidence of a lesion or disease of the somatosensory system and relating it plausibly to the pain. Clinical neurological examination assesses sensation, reflexes, strength and distribution. Nerve-conduction studies and electromyography can help evaluate peripheral nerve and motor involvement, although small-fibre neuropathy may occur despite relatively normal standard nerve-conduction tests. Blood investigations can identify common causes such as diabetes or nutritional deficiency when appropriate. Imaging may be important when spinal cord, nerve-root or central lesions are suspected. NICE notes that a distal “glove and stocking” pattern can suggest peripheral neuropathy, whereas brisk reflexes may point towards a central nervous system cause rather than peripheral neuropathy.

Treatment of neuropathic pain differs from treatment of many forms of inflammatory or mechanical pain because conventional analgesics may be less effective. Depending on the cause and patient circumstances, medicines used specifically for neuropathic pain can include certain antidepressants and antiseizure medicines, while topical treatments may be appropriate for localised peripheral neuropathic pain.

Treating the underlying disease is also important: improving diabetes control, correcting a nutritional deficiency or relieving a causative compression may prevent further nerve damage even if established pain does not disappear immediately. Medication choice depends on adverse effects, interactions, kidney and liver function, age and comorbidities. Drug treatment should generally be combined with functional rehabilitation and education rather than viewed as a complete solution.

Neuropathic pain can arise from numerous conditions, including diabetes, shingles, nerve trauma, chemotherapy-related nerve damage, nerve compression, spinal cord injury and some neurological diseases. Multiple Sclerosis can produce neuropathic pain through central nervous system lesions, while spinal cord injury can produce pain below or around the level of injury through abnormal sensory pathway activity. The underlying disease and the pain mechanism should therefore be described separately. A person with diabetes may have neuropathic pain, but diabetes itself is not synonymous with neuropathic pain. Similarly, sciatica can include neuropathic features when a nerve root is affected, but not every episode of back or leg pain is neuropathic.

Persistent neuropathic pain can have major effects on sleep, mobility, mood, concentration and quality of life. Because the pain may be disproportionate to visible tissue damage, patients can encounter misunderstanding when clinical examinations or scans appear relatively normal. Objective sensory abnormalities can provide useful supporting evidence, but severe neuropathic pain can occur with subtle findings. Psychological distress can increase the burden of neuropathic pain without making the underlying nerve lesion psychological. Management therefore benefits from clear explanation of the mechanism, realistic treatment goals and monitoring for medication adverse effects. Complete pain elimination is not always achievable, and meaningful improvement may instead involve reduced pain intensity, better sleep and increased activity.

Neuropathic pain is fundamentally a mechanism-based diagnosis rather than simply a synonym for severe or chronic pain. Its defining feature is disease or lesion of the somatosensory nervous system, whereas chronic pain refers primarily to persistence and can include several mechanisms. Neuropathic pain may be peripheral or central and can coexist with nociceptive or nociplastic mechanisms. Its characteristic sensory phenomena arise from altered neuronal excitability, abnormal signal transmission and changes in central processing. Correct identification matters because the treatment strategy differs from that used for many forms of ordinary tissue pain.